Advancing and introducing diagnostics
We support the development and introduction of purpose-built diagnostic solutions for diseases and conditions in low- and middle-income countries.
PATH Diagnostics helps to support the introduction of new diagnostic tools and approaches by defining product requirements, advancing prototype designs, and assessing prototypes including benchmarking, performance assessment, and the availability of curated specimens.
We maintain a laboratory in Seattle, Washington, which houses state-of-the-art instrumentation operated by a highly skilled workforce.
Quality Assurance Programs
PATH Diagnostics develops and implements quality assurance programs to ensure the validity and accuracy of test results. This includes material selection and implementation, procedures for high-quality manufacturing and shipping, end-user (operator) training, reporting and procurement, and supply chain procedures.
Resources
- COVID-19 Diagnostics Benchmarking Panel
- Supporting WHO Emergency Use Listing through independent evaluation of COVID-19 diagnostics
- How portfolio-based product development can accelerate progress in global health
- G6PD diagnostics: Improving health outcomes and breaking the cycle of malaria transmission
